Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any age, gender, race, or ethnic background
- People who speak Spanish as their primary language
- People who have had brain imaging (such as an MRI) that suggests a brain tumor, or who have had a biopsy of a tumor, before planned surgery to remove it
- People who are able and willing to give their own informed consent, or, for those under 18, whose parent or legal guardian is willing and able to give consent on their behalf
- People with a Karnofsky Performance Score above 70% — this is a medical measure of overall health and ability to carry out daily activities (confirm with trial site)
- People who are not pregnant, or who have had pregnancy ruled out by a blood test, or whose ability to become pregnant has ended due to surgery, radiation, or menopause, or who are currently using two approved forms of birth control
Who may not be able to join:
- People, or the parent/guardian of a minor, who are unable to provide informed consent
- People with a Karnofsky Performance Score below 70% — meaning those whose health or daily functioning is significantly limited (confirm with trial site)
- People who experience claustrophobia (fear of enclosed spaces) or who have metal devices in their body that are not compatible with MRI, such as a pacemaker, vascular or surgical clips, prosthetic heart valves, or certain ear implants
- People with severe heart failure classified as NYHA Class III or IV (a medical measure of serious heart condition — confirm with trial site)
- People with psychiatric conditions or addiction issues that would prevent them from giving informed consent
- People experiencing unstable angina (a serious type of chest pain related to the heart)
- Women who are pregnant or currently breastfeeding
- Women who could become pregnant and who decline to take a pregnancy test during the screening process
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elizabeth Maher, MD, PhD, University of Texas
Phone: 214-648-7097
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
metabolic phenotype correlation to clinical endpoints
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.